The trading price of Protalix BioTherapeutics Inc (AMEX:PLX) closed higher on Monday, November 18, and closing at $1.66, 18.57% higher than its previous close.
Traders who pay close attention to intraday price movement should know that it fluctuated between $1.405 and $1.7199. In examining the 52-week price action we see that the stock hit a 52-week high of $1.90 and a 52-week low of $0.82. Over the past month, the stock has gained 52.29% in value.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Protalix BioTherapeutics Inc, whose market valuation is $121.37 million at the time of this writing, is expected to release its quarterly earnings report in December. Investors’ optimism about the company’s current quarter earnings report is understandable.
On the technical side, indicators suggest PLX has a 100% Buy on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Buy, while an average of long term indicators suggests that the stock is currently 50% Buy.
A quick review shows that PLX’s price is currently 35.90% off the SMA20 and 47.37% off the SMA50. The RSI metric on the 14-day chart is currently showing 76.90, and weekly volatility stands at 11.88%. When measured over the past 30 days, the indicator reaches 6.44%. Protalix BioTherapeutics Inc (AMEX:PLX)’s beta value is currently sitting at 0.64, while the Average True Range indicator is currently displaying 0.09.
To see how Protalix BioTherapeutics Inc stock has been performing in comparison to its peers in the industry, here are the numbers: PLX stock’s performance was 18.57% in the latest trading, and 19.42% in the past year.
An evaluation of the daily trading volume of Protalix BioTherapeutics Inc (AMEX:PLX) indicates that the 3-month average is 191.02K. However, this figure has increased over the past 10 days to an average of 0.46.
Currently, records show that 72.95 million of the company’s shares remain outstanding. The insiders hold 14.48% of outstanding shares, whereas institutions hold 5.10%. The stats also highlight that short interest as of 2024-10-31, stood at 3.1 million shares, resulting in a short ratio of 22.71 at that time. From this, we can conclude that short interest is 441.00 of the company’s total outstanding shares. It is noteworthy that short shares in October were down slightly from the previous month’s figure, which was 3.13 million. However, since the stock’s price has seen -6.74% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
